Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 11-2020 | 08-2020 | 05-2020 | 02-2020 | 11-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,435 | N/A | -3,628 | -2,677 | -1,306 |
| Other Working Capital | 64 | N/A | -144 | -22 | 116 |
| Other Operating Activity | 51 | 0 | 297 | 244 | 139 |
| Operating Cash Flow | $-1,320 | $N/A | $-3,475 | $-2,454 | $-1,052 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -1 | -1 | N/A |
| Investing Cash Flow | $N/A | $N/A | $-1 | $-1 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,579 | N/A | 381 | N/A | N/A |
| Other Financing Activity | 0 | 0 | -110 | -12 | -14 |
| Financing Cash Flow | $6,579 | $N/A | $271 | $-12 | $-14 |
| Exchange Rate Effect | -12 | N/A | 60 | 26 | 16 |
| Beginning Cash Position | 2,142 | N/A | 4,424 | 4,424 | 4,424 |
| End Cash Position | 7,389 | N/A | 1,279 | 1,983 | 3,375 |
| Net Cash Flow | $5,247 | $N/A | $-3,145 | $-2,441 | $-1,049 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,320 | N/A | -3,475 | -2,454 | -1,052 |
| Capital Expenditure | N/A | N/A | -1 | -1 | N/A |
| Free Cash Flow | -1,320 | 0 | -3,476 | -2,455 | -1,052 |